Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors-Reference-Cited by-同舟云学术

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors

Published:2020-02-07 Issue:6 Volume: Page:699-715
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Xu Qing-Yu,Yu Li

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference109 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

3. An update of current treatments for adult acute myeloid leukemia;Dombret;Blood,2016

4. Prediction of acute myeloid leukaemia risk in healthy individuals;Abelson;Nature,2018

5. Selecting initial treatment of acute myeloid leukaemia in older adults;Podoltsev;Blood Rev,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity;Journal of Medicinal Chemistry;2024-09-12

2. Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets;Frontiers in Pharmacology;2024-06-04

3. The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells;American Journal of Cancer Research;2024

4. NK cell defects: implication in acute myeloid leukemia;Frontiers in Immunology;2023-05-09

5. Advances in the Treatment of Senile Acute Myeloid Leukemia;Advances in Clinical Medicine;2023